Princess Eugenie tells of her childhood scoliosis surgery
Princess Eugenie has opened up about her experience of scoliosis surgery as a child amid her ongoing support for patients with spinal injuries.
The 35-year-old is patron of Horatio's Garden, a charity that creates peaceful garden spaces for spinal injury patients, and visited the charity's garden at Salisbury District Hospital this week.
In an interview with the Telegraph, she reflected on her spinal surgery at age 12, and expressed strong support for the charity's work.
She said: 'Horatio's Garden's mission is to reach every spinal injuries unit in the UK. I'm happy to be on that journey with them. It needs to happen.'
The princess, 12th in line to the throne, recalled her own recovery at the Royal National Orthopaedic Hospital in Stanmore, where she spent 10 days on her back after surgeons inserted titanium rods into her spine to correct curvature caused by scoliosis.
She told the Telegraph: 'I couldn't get out of bed or do anything for myself', adding that she felt 'very embarrassed' ahead of the operation and later struggled with the emotional impact of post-surgery care.
It was four months before she was able to return to school.
She also spoke about the emotional impact of surgery, recalling how it was her mother, Sarah, Duchess of York, who helped her see her surgical scar as a 'badge of honour'.
Eugenie said: 'She'd (Sarah) turn me around and say, 'my daughter is superhuman, you've got to check out her scar'.'
At her 2018 wedding, Eugenie wore a dress that revealed her scar to raise awareness of scoliosis.
Eugenie said she often received messages from anxious parents whose children are about to undergo spinal surgery, and she makes a point of offering encouragement and reassurance to help them through the experience.
She added: 'I tell them not to feel ashamed, not just of the scar but of the whole experience; bed pans, the lot.'
Now a working mother of two, Eugenie juggles charity work alongside her role at international gallery Hauser & Wirth and said she and sister Beatrice feel a strong sense of duty to help others because of guidance from their grandmother, the late Queen.
She said: 'My mum always taught me that giving back to others is the most important thing in life.
'Bea and I feel very strongly about this.
'My grandmother's sense of duty was also instilled from a young age; we watched my parents, my granny and other family members working very hard.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
3 hours ago
- Associated Press
England fast bowler Brydon Carse considered getting toe amputated
LONDON (AP) — England fast bowler Brydon Carse said he considered getting a toe amputated after encountering longstanding problems because of his bowling action. The damage to his second toe on his left foot became so bad over the winter when playing for England that Carse was forced to pull out midway through its Champions Trophy campaign in Pakistan and withdraw from a lucrative deal in the Indian Premier League. The 29-year-old Carse explored every option to deal with the issue, including a drastic remedy. 'It ended up being quite a severe wound I was playing with for the majority of the winter. It got infected a couple of times,' said Carse, speaking on Thursday ahead of England's first Twenty20 against the West Indies on Friday. 'It is a bit of a running joke in the changing room, my second toe. So we came up with the thought, 'Can we just get rid of the second toe?' 'Everyone has had their opinion on my second toe. At one stage I was going to bed thinking, 'I could actually do this, I think I could get rid of my second toe.' But then the medical staff said you need it for balance so that was quickly ruled out.' England test captain Ben Stokes' late father, Ged, famously took a similar course of action in his rugby league days, removing his middle finger at the knuckle to speed up his return to action. Carse has just returned to action and was picked on Thursday in England's 14-man squad for the five-match test series against India. ___ AP cricket:
Medscape
3 hours ago
- Medscape
MHRA Urges Contraception With GLP-1 Weight-Loss Drugs
The Medicines and Healthcare products Regulatory Agency (MHRA) has reiterated that women using weight-loss drugs must use effective contraception, as the risks of these drugs to a foetus remain unclear. The warning follows concerns that some users in the UK may not be taking glucagon-like peptide-1 receptor agonists (GLP-1s) safely. To date, the MHRA has received more than 40 reports relating to pregnancies in women taking these medications. 'These medicines must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding,' the MHRA stated. Women who become pregnant while using these drugs should stop treatment immediately and consult a healthcare professional. There is not enough safety data to determine if the drugs could harm a developing baby, the agency said. Avoid Unregulated Sellers, MHRA Warns The MHRA also warned against buying these drugs from unregulated sources such as beauty salons or via social media. 'Not only does this expose people wanting to lose weight to serious health risks, it is also against the law to sell these medicines in this way,' said Dr Alison Cave, the MHRA's chief safety officer. The agency emphasised that weight-loss drugs should not be taken without first consulting a healthcare professional. 'The only way to guarantee receiving a genuine GLP-1 medicine is to obtain it from a legitimate pharmacy,' Cave said. Pharmacies Seeing High Demand 'Community pharmacies have been experiencing unprecedented levels of interest for weight loss injections,' said Jasmine Shah, medication safety officer at the National Pharmacy Association. 'It is therefore important that regulations and guidance keep pace with this demand.' Mounjaro May Lower Effectiveness of Oral Contraceptives The MHRA noted that Mounjaro (tirzepatide) may reduce the effectiveness of oral contraceptives in people with overweight or obesity. Women taking Mounjaro should use a non-oral contraceptive method for 4 weeks after starting the drug and for 4 weeks after any dose increase. This advice applies only to Mounjaro users. Patients are also advised to be alert for signs of acute pancreatitis. Risks in Pregnancy Remain Unclear 'There is hardly any available data from human studies to be able to advise if these weight loss drugs are safe in pregnancy,' said Rebecca Reynolds, professor of metabolic medicine at the University of Edinburgh. 'The data from animal studies suggests the potential for harm with low birthweight and skeletal abnormalities, though more evidence is needed to assess if there are risks of taking these drugs in humans,' she told the Science Media Centre (SMC). Dr Bassel Wattar, consultant obstetrician and gynaecologist at Epsom and St Helier University Hospitals, supported the MHRA's warning. 'There is some data from animal studies suggesting there is a risk of malformation to the foetus — in animals falling pregnant while taking GLP-1 agonists — but data remains limited in humans,' he said. However, Dr Caroline Ovadia, senior clinical lecturer in obstetrics at the University of Edinburgh, noted to the SMC that existing human cohort studies had not shown clear evidence of harm. Online Buyers May Miss Safety Guidance Although direct evidence linking GLP-1 drugs to contraceptive failure is limited, the high number of users means even a small risk could have public health implications, experts warned. Professor Ying Cheong, consultant in reproductive medicine at the University of Southampton, speaking to the SMC, said that gastrointestinal side effects, such as vomiting and diarrhoea, could impair oral contraceptive absorption, increasing the risk of unintended pregnancy. 'Many people are buying weight loss drugs online and so may not receive this important advice about contraception,' Reynolds pointed out. 'These are not harmless lifestyle drugs,' stressed Cheong. 'The public urgently needs to understand that these medications require proper medical supervision to avoid unintended harm, particularly to reproductive health.'
Medscape
4 hours ago
- Medscape
GMC Updates Fitness to Practise Rules Amid PA Criticism
The General Medical Council (GMC) has published updated fitness to practise guidance aimed at providing greater clarity and consistency in handling concerns about medical professionals in the UK. The changes follow long-standing criticisms of the GMC's approach to fitness to practise (FtP) investigations and its promises to introduce more compassionate procedures. However, the updated guidance drew immediate criticism for treating doctors under the same regulatory framework as physician associates (PAs) and anaesthesia associates (AAs). Key Changes to Assessment Process The updates to FtP guidance provide case examiners with a framework for assessing whether concerns received by the GMC should be interpreted as meaning that a doctor may pose a risk to the public. This follows changes made last year by the regulator to investigations involving violence and dishonesty. These gave decision-makers more discretion in minor cases judged to represent a lower risk to public protection. The new guidance introduces three core questions for decision-makers when assessing whether concerns should proceed to investigation: What is the seriousness of the concern? What is the impact of relevant context? How has the doctor responded? Factors that may increase seriousness include repeat behaviour, abuse of position, or allegations involving vulnerable individuals. Decision-makers will also consider working environment, personal circumstances, and whether the professional has shown insight and remediation. Investigation Triggers Fitness to practise investigations may still be initiated for: Misconduct Poor performance Criminal conviction or caution Physical or mental ill-health affecting practice Determination by another regulatory body Insufficient knowledge of English The thresholds for FtP concerns remain unchanged, but the assessment process will be more structured. The Medical Protection Society (MPS) welcomed the GMC's efforts 'to deliver a fitness to practise process that is fairer and more compassionate'. Dr Rob Hendry, the society's medical director, told Medscape News UK : 'Finding out that fitness to practise is being called into question can have a significant impact on a doctor's mental wellbeing.' He added that the MPS had 'long called for more to be done to ensure doctors are not dragged through this stressful process unnecessarily'. Doctors' Association Raises Concerns The new guidance brings FtP decisions for doctors into line with how cases involving PAs and AAs are considered. The GMC assumed responsibility for regulation of PAs and AAs in December 2024. The move was vigorously opposed by many in the medical profession, particularly by GPs who wanted medical associates kept out of general practice altogether. The Doctors' Association UK (DAUK) appreciated the GMC's attempt to clarify its guidance but expressed concern about aligning doctor regulation with PA and AA processes. Helen Fernandes, DAUK chair, highlighted that the GMC has not set standards or scope of clinical practice for medical associates. 'If there was an issue around the clinical decision-making of a PA or AA, there are no standards against which they can be judged," she told Medscape News UK . This contrasts with doctors' clinical conduct being assessed against strict standards for many years. DAUK has expressed unease about how doctors will be held accountable for supervising PAs and AAs, noting that the GMC has attributed supervision responsibilities to anyone working with them in a team. "This guidance seems to add more confusion to an already confused picture, which we believe doesn't help our members – but more importantly, doesn't help our patients or the wider public," Fernandes said. The updated guidance is available on the GMC's website.
